Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01052415 · ClinicalTrials.gov registry record · NA
POL and Access Intervention to Reduce HIV Stigma Among Service Providers in China
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 5,400
- Enrollment target
NCT01052415 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 5,400 participants.
The verdict
NCT01052415, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,400 participants
- Enrollment target
Study Summary
In this project, UCLA's Center for Community Health (CCH) will develop an efficacious intervention trial integrating both individual and structural components to reduce HIV- related stigma among service providers in China and therefore benefit people living with HIV/AIDS (PLWHA). The purpose of this study is to develop a feasible, practical and low cost intervention strategy that will prevent and/or reduce the negative effects of HIV-related stigma among health service providers in China. This project will be conducted in two provinces and proceed in two phases. In Phase 1, confidential focus groups will take place with small samples of service providers and hospital administrators to finalize the intervention activities, and the investigators will also test and finalize the Audio Computer-Assisted Self-Interview (ACASI) assessment measures and implementation procedures with the same group of service providers. During Phase 1 a small sample of patients will anonymously test the paper-pencil baseline survey. Equal number of samples will be selected from two counties of each province. The findings from Phase 1 will be used to develop intervention, and revise assessment for Phase 2.
Interventions
- BEHAVIORAL Cognitive behavioral sessions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,400 participants |
| Start Date | 2007-09 |
| Est. Completion | 2011-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01052415
The ClinicalTrials.gov registry entry for NCT01052415 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5,400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive behavioral sessions is the first listed.
NCT01052415 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01052415 about?
NCT01052415 is a clinical study titled "POL and Access Intervention to Reduce HIV Stigma Among Service Providers in China". In this project, UCLA's Center for Community Health (CCH) will develop an efficacious intervention trial integrating both individual and structural components to reduce HIV- related stigma among service providers in China and therefore benefit people living with HIV/AIDS (PLWHA). The purpose of thi...
What is the current status of trial NCT01052415?
This trial is currently completed. It is a NA study. The enrollment target is 5,400 participants. The study started on 2007-09. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01052415?
The interventions under investigation include: Cognitive behavioral sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT01052415?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.